A Phase 1 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

April 17, 2024

Primary Completion Date

April 29, 2027

Study Completion Date

April 29, 2030

Conditions
Advanced Solid Tumors
Interventions
DRUG

YL201

YL201 (High dose, medium dose and low dose; Q3W) in Combination with Serplulimab (4.5mg/kg; Q3W) with or without Platinum(70 mg/m2; Q3W)-based Chemotherapy.

Trial Locations (30)

Unknown

NOT_YET_RECRUITING

Peking University Cancer Hospital, Beijing

NOT_YET_RECRUITING

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

RECRUITING

Chongqing University Cancer Hospital, Chongqing

NOT_YET_RECRUITING

Fujian Provincial Cancer Hospital, Fuzhou

NOT_YET_RECRUITING

The First Affiliated Hospital of Fujian Medical University, Fuzhou

NOT_YET_RECRUITING

The First Hospital of Lanzhou University, Lanzhou

RECRUITING

Sun Yat-Sen University Cancer Center, Guangzhou

RECRUITING

Affiliated Cancer Hospital of Guangxi Medical University, Nanning

NOT_YET_RECRUITING

Guangxi Zhuang Autonomous Region People's Hospital, Nanning

NOT_YET_RECRUITING

The First Affiliated Hospital of Hainan Medical College, Haikou

NOT_YET_RECRUITING

The Fourth Hospital of Hebei Medical University, Shijiazhuang

NOT_YET_RECRUITING

Cancer Hospital Affiliated to Harbin Medical University, Harbin

RECRUITING

Henan Cancer Hospital, Zhengzhou

RECRUITING

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

NOT_YET_RECRUITING

Hubei Provincial Cancer Hospital, Wuhan

RECRUITING

Union Hospital Tongji Medical College HuaZhong University of Science Technology, Wuhan

RECRUITING

Hunan Cancer Hospital, Changsha

RECRUITING

Jiangxi Cancer Hospital, Nanchang

RECRUITING

The First Affiliated Hospital of Nanchang University, Nanchang

NOT_YET_RECRUITING

The First Hospital of Jilin University, Changhua

NOT_YET_RECRUITING

Liaoning Provincial Cancer Hospital, Shenyang

RECRUITING

Shandong Cancer Hospital and Institute, Jinan

NOT_YET_RECRUITING

Linyi Central Hospital, Linyi

NOT_YET_RECRUITING

Zaozhuang Municipal Hospital, Zaozhuang

RECRUITING

West China Hospital of Sichuan University, Chengdu

RECRUITING

West China Hospital, Sichuan University, Sichuan

NOT_YET_RECRUITING

Tianjin Cancer Hospital, Tianjin

RECRUITING

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

NOT_YET_RECRUITING

Zhejiang Provincial Cancer Hospital, Hangzhou

RECRUITING

Taizhou Hospital of Zhejiang Province, Taizhou

All Listed Sponsors
lead

MediLink Therapeutics (Suzhou) Co., Ltd.

INDUSTRY